Progressive Multifocal Leukoencephalopathy
Links shared publicly online about this topic
Progressive multifocal leukoencephalopathy - Wikipedia, the free encyclopedia
en.wikipedia.org — “Progressive multifocal leukoencephalopathy - Wikipedia, the free encyclopedia” View full resource at en.wikipedia.org
Most Recently Shared on February 20, 2009 at 1:15 pm By:
eyeonfda Health Lawyer and Pharma
Raptiva recommended for with drawal in EMEA because of PML - Here is what PML is http://bit.ly/3wPYo6
Tysabri (natalizumab), PML (progressive multifocal leukoencephalopathy), and Ongoing Research - Multiple Sclerosis
healthcentral.com — “Of the available disease-modifying treatments for multiple sclerosis, Tysabri (natalizumab) has arguably been the most controversial to date. The reason f...” View full resource at healthcentral.com
Most Recently Shared on December 17, 2010 at 2:27 am By:
Tysabri (natalizumab), PML (progressive multifocal leukoencephalopathy), and Ongoing Research http://ow.ly/1ausyL
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
neurology.org — “Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy” View full resource at neurology.org
Most Recently Shared on May 19, 2011 at 12:05 pm By:
Neurology Journal Neurology and Medical Journal
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy http://bit.ly/iWCksZ #neurology
FDA warns of progressive multifocal leukoencephalopathy (PML) risk with Tysabri - MPR
empr.com — “The FDA continues to receive reports of progressive multifocal leukoencephalopathy (PML) in patients treated with Tysabri (natalizumab, from Biogen Idec).” View full resource at empr.com
Most Recently Shared on September 22, 2009 at 3:37 pm By:
MPR News: FDA warns of progressive multifocal leukoencephalopathy (PML) risk with Tysabri: The FDA cont.. http://bit.ly/ke2nc
Tysabri labeling to include safety information on risk of progressive multifocal leukoencephalopathy - MPR
empr.com — “The FDA has notified healthcare professionals and patients that the risk of developing progressive multifocal leukoencephalopathy (PML) increases with the number of Tysabri (natalizumab, from Biogen Idec) infusions received.” View full resource at empr.com
Most Recently Shared on February 5, 2010 at 6:44 pm By:
MPR News: Tysabri labeling to include safety information on risk of progressive multifocal leukoencephalopathy: Th... http://bit.ly/9G7EQr
Progressive Multifocal Leukoencephalopathy: Infections of the Brain and Spinal Cord: Merck Manual Home Edition
merck.com — “Progressive Multifocal Leukoencephalopathy: Infections of the Brain and Spinal Cord: Merck Manual Home Edition” View full resource at merck.com
Most Recently Shared on June 10, 2010 at 11:50 am By:
Infections of the Brain and Spinal Cord: Symptoms, diagnosis, & treatment of progressive multifocal leukoencephalopathy http://bit.ly/922Nfa
European Medicines Agency Recommends Additional Measures To Better Manage Risk Of Progressive Multifocal Leukoencephalopathy (PML) With Tysabri
medicalnewstoday.com — “The European Medicines Agency has finalised a review of Tysabri (natalizumab) and the risk of progressive multifocal leukoencephalopathy (PML), a rare brain infection caused by the JC virus. The A” View full resource at medicalnewstoday.com
Most Recently Shared on January 22, 2010 at 12:37 pm By:
European Medicines Agency Recommends Additional Measures To Better Manage Risk Of Progressive Multifocal Leukoencepha.. http://bit.ly/5suA94
Adcetris (brentuximab vedotin): Drug Safety Communication - Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity
fda.gov — “New Boxed Warning and Contraindication highlighting these risks added to product labeling.” View full resource at fda.gov
Most Recently Shared on January 13, 2012 at 5:25 pm By:
Ramsey Baghdadi Health Communicator
two new cases of PML with Seattle Genetics' Adcetris: http://t.co/lb13qx7p
PolygenicBlog: JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab.
polygenicpathways.blogspot.com — “Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue” View full resource at polygenicpathways.blogspot.com
Most Recently Shared on September 25, 2010 at 11:17 am By:
http://www.linkedin.com/pub/chris-carter/22/560/76a" /> Dr Chris Carter Doctor, Medical Technology, Pharmacist, and PhD
JC virus persistence following progressive multifocal leukoencephalopathy in multiple… http://goo.gl/fb/Ko6Nx
Arch Neurol -- Abstract: Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis, July 12, 2010, Schröder et al. 0 (2010): archneurol.2010.157v
archneur.ama-assn.org — “Archives of Neurology, a monthly professional medical journal published by the American Medical Association, publishes original, peer-reviewed scientific research on the nervous system” View full resource at archneur.ama-assn.org
Most Recently Shared on July 13, 2010 at 11:49 am By:
Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstituti... http://bit.ly/9Z6Ek9
Rheumatology Article | Leukoencephalopathy, Progressive Multifocal
mdlinx.com — “Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis” View full resource at mdlinx.com
Most Recently Shared on September 15, 2011 at 10:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis: Archives ... http://t.co/RszV26wc #Rheumatology
Neurology Article | Leukoencephalopathy, Progressive Multifocal
mdlinx.com — “Immunological and clinical consequences of treating a patient with natalizumab” View full resource at mdlinx.com
Most Recently Shared on September 19, 2011 at 9:04 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Immunological and clinical consequences of treating a patient with natalizumab: Multiple Sclerosis http://t.co/k7QiFN4q #neuro
Family Medicine News & Articles - MDLinx - Leukoencephalopathy, Progressive Multifocal on #MDlinx
mdlinx.com — “Family Medicine News & Articles - MDLinx - Leukoencephalopathy, Progressive Multifocal on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 14, 2010 at 6:15 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patient... http://bit.ly/arD7lr #GM #mdlinx
Pediatrics News & Articles - MDLinx - Leukoencephalopathy, Progressive Multifocal on #MDlinx
mdlinx.com — “Pediatrics News & Articles - MDLinx - Leukoencephalopathy, Progressive Multifocal on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on July 22, 2010 at 5:11 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Leukoencephalopathy with Anterior Temporal Cysts Due to Congenital CMV Infection Diagnosed Retrospectively: J... http://bit.ly/dBDRBq #peds
Emergency Medicine News & Articles - MDLinx - Leukoencephalopathy, Progressive Multifocal on #MDlinx
mdlinx.com — “Emergency Medicine News & Articles - MDLinx - Leukoencephalopathy, Progressive Multifocal on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 14, 2010 at 2:05 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Henoch-Schonlein Purpura Complicated by Reversible Posterior Leukoencephalopathy Syndrome: Pediatric Em... http://bit.ly/aDqTli #ER #mdlinx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
-
Neurology Journal
Advertisement
